COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern Characteristics
Recruiting
Observational Study
Sars-CoV-2 Infection
COVID-19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,188 (estimated)
- Sponsor
- Direction Centrale du Service de Santé des Armées · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In some clinical forms of COVID-19, an uncontrolled hyper-inflammatory reaction known as a "cytokine storm" appears abruptly, around day 7, and is associated with rapid respiratory deterioration, requiring hospitalization in an intensive care unit (ICU).
At present, although risk factors for this severe form have been described, there are no validated criteria for determining which individual pat…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* French speaking
* Affiliated to a social security system
* Owning a mobile phone capable of accessing the COVOICE application
Exclusion Criteria:
* Incapable adults
* People deprived of their liberty
* People under administrative or judicial supervision
* Patients intubated …
Contacts